MathewShaneMaurerMD

Heart Failure & Transplantation, Cardiovascular Disease Genetics

Associate Professor, Medicine, Columbia University College of Phys & Surg

Overview of Dr. Maurer

Dr. Mathew Maurer is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Mount Sinai School of Medicine and has been in practice 25 years. He specializes in cardiac amyloidosis, geriatric cardiology and heart failure & transplantation.

Office
173 Fort Washington Avenue
Floor 4, Suite 617
New York, NY 10032
Book by Phone+1(615) 412-0550

Education & Training

New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 1996 - 1999
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1992 - 1996
Icahn School of Medicine at Mount SinaiClass of 1992

Certifications & Licensure

FL State Medical License 2020 - Present
NY State Medical License 1992 - 2025
NY State Medical License 1994 - 2025

Awards, Honors, & Recognition

New York Magazine: Top Doctors Castle Connolly, 2014
Fellow (FACC) American College of Cardiology

Clinical Trials

Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) Start of enrollment: 2007 Jul 01
Completed
Phase 2
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure Start of enrollment: 2010 Oct 01
Terminated
Phase 4
Geriatric Out of Hospital Randomized Meal Trial in Heart Failure Start of enrollment: 2014 May 01
Completed
Not Applicable
Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations Start of enrollment: 2019 May 15
Recruiting
Roles: Contact, Principal Investigator, Sponsor-Investigator
High Calorie High Protein Nutrition Supplementation in Advanced Heart Failure Start of enrollment: 2022 Apr 05
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis Start of enrollment: 2023 Sep 19
Recruiting
Roles: Contact, Principal Investigator
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR Start of enrollment: 2022 Jul 08
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

743 citations
Frailty Assessment in the Cardiovascular Care of Older Adults
Jonathan Afilalo, Karen P. Alexander, Michael J. Mack, Mathew S. Maurer, Philip Green
Journal of the American College of Cardiology. 2014-03-04
351 citations
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.
Philip Green, Abigail E. Woglom, Philippe Généreux, Benoit Daneault, Jean-Michel Paradis
JACC. Cardiovascular Interventions. 2012-09-01
443 citations
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P. Abraham, Ahmad Masri
Lancet. 2020-09-12

Journal Articles

Insufficient Calorie Intake Worsens Post-Discharge Quality of Life and Increases Readmission Burden in Heart Failure
Hannah R Rosenblum, Mathew S Maurer, Scott L Hummel, JACC: Heart Failure
Early Diagnosis of Cardiac Amyloidosis by Carpal Tunnel Surgery
Frederick L Ruberg, Mathew S Maurer, ScienceDirect
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Mathew S Maurer, Mazen Hanna, Martha Grogan, Marla B Sultan, Sanjiv J Shah, The New England Journal of Medicine

Lectures

A Heart Biopsy Must not be do?e: The Role of Imaging and Newer Diagnostic Strategies
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Get the Diagnosis Right: Identifying Amyloidosis in Your Patients
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Are You Infiltrated or Just fat? Should we Screen for Infiltrative Disease Prior to Aortic Valve Replacement?.
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Multimorbidity in Older Adults with Cardiovascular Disease
Columbia University Medical Center, New York, New York - 5/17/2012
Hypertrophic & Restrictive Cardiomyopathy: Genetics, Imaging and Emerging Treatments in Adult and Pediatric Patients
Columbia University, Department of Surgery, New York, New York - 3/13/2013
Join now to see all

Authored Content

Clinical Outcomes of Older Adults in the US Listed for Heart TransplantationNovember 2021
ACC CardiaCast: Understanding AL and ATTR Cardiac AmyloidosisMarch 2021
More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac AmyloidosisJanuary 2018
More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac AmyloidosisJanuary 2018
Myocardial Contraction Fraction A Volumetric Measure of Myocardial Shortening Analogous to StrainJanuary 2018
Myocardial Contraction Fraction A Volumetric Measure of Myocardial Shortening Analogous to StrainJanuary 2018
Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF)June 2015
Join now to see all

Press Mentions

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CMOctober 4th, 2024
REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise TestsMarch 22nd, 2023
Alnylam Presents Positive Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with CardiomyopathySeptember 8th, 2022
Join now to see all

Grant Support

Midcareer Mentoring Award For Patient Oriented Research In Geriatric CardiologyNational Institute On Aging2010–2011
Pathophysiology Of Heart Failure With A Normal Ejection Fraction In The ElderlyNational Institute On Aging2007–2010
Cardiovascular Causes Of Falls/Syncope In The ElderlyNational Institute On Aging2001–2005